Composite Psoriatic Disease Activity Index (CPDAI), Defining Remission and Disease Activity States Using Data from Daily Clinical Practice

被引：0
|
作者：
Acosta Felquer, Maria Laura [1 ,2 ]
Szentpetery, Agnes [3 ,4 ,5 ,6 ]
Elmamoun, Musaab [3 ]
Gallagher, Phil [5 ]
FitzGerald, Oliver [7 ]
Soriano, Enrique R. [1 ,2 ]
机构：
[1] Hosp Italiano Buenos Aires, Inst Univ Hosp Italiano Buenos Aires, Internal Med Serv, Rheumatol Unit, Buenos Aires, DF, Argentina
[2] Fdn PM Catoggio, Buenos Aires, DF, Argentina
[3] St Vincents Univ Hosp, Dept Rheumatol, Rheumatol, Dublin 4, Ireland
[4] St Vincents Univ Hosp, Dublin Acad Med Ctr, Rheumatol, Dublin, Ireland
[5] St Vincents Univ Hosp, Dept Rheumatol, Dublin, Ireland
[6] St Vincents Univ Hosp, Dept Rheumatol, Bone & Joint Unit, Dublin, Ireland
[7] Univ Coll Dublin, St Vincents Univ Hosp, Dept Rheumatol, Conway Inst Biomol & Biomed Res, Dublin, Ireland
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1723
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Development of Composite Psoriatic Disease Activity Index (CPDAI) in psoriatic arthritis
    Mumtaz, A.
    Gallagher, P.
    Kirby, B.
    Coates, L. C.
    Waxman, R.
    Veale, D. J.
    Heliwell, P.
    FitzGerald, O.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2010, 179 : S546 - S547
  • [2] FURTHER ANALYSIS OF PSORIATIC ARTHRITIS DISEASE ACTIVITY SCORE (PASDAS) AND COMPOSITE PSORIATIC DISEASE ACTIVITY INDEX (CPDAI) USING DATA FROM A PLACEBO-CONTROLLED TRIAL OF CERTOLIZUMAB PEGOL IN PSORIATIC ARTHRITIS
    Helliwell, P.
    Mease, P. J.
    Nurminen, T.
    FitzGerald, O.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 740 - 740
  • [3] Does Gender Make a Difference in "Composite Psoriatic Disease Activity Index (CPDAI)" in Patients with Psoriatic Arthritis?
    Kenar, Gokce
    Yarkan, Handan
    Zengin, Berrin
    Can, Gercek
    Birlik, Merih
    Akkoc, Nurullah
    Onen, Fatos
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [4] Gender does not make a difference in “composite psoriatic disease activity index (CPDAI)” in patients with psoriatic arthritis
    Gökçe Kenar
    Handan Yarkan
    Berrin Zengin
    Gerçek Can
    Merih Birlik
    Fatoş Önen
    [J]. Rheumatology International, 2018, 38 : 2069 - 2076
  • [5] Gender does not make a difference in "composite psoriatic disease activity index (CPDAI)" in patients with psoriatic arthritis
    Kenar, Gokce
    Yarkan, Handan
    Zengin, Berrin
    Can, Gercek
    Birlik, Merih
    Onen, Fatos
    [J]. RHEUMATOLOGY INTERNATIONAL, 2018, 38 (11) : 2069 - 2076
  • [6] Defining Low Disease Activity States in Psoriatic Arthritis using Novel Composite Disease Instruments
    Coates, Laura C.
    Helliwell, Philip S.
    [J]. JOURNAL OF RHEUMATOLOGY, 2016, 43 (02) : 371 - 375
  • [7] Defining Low Disease Activity States in Psoriatic Arthritis Using Novel Composite Disease Instruments
    Lubrano, Ennio
    Perrotta, Fabio Massimo
    [J]. JOURNAL OF RHEUMATOLOGY, 2016, 43 (09) : 1765 - +
  • [8] Defining Low Disease Activity States in Psoriatic Arthritis Using Novel Composite Disease Instruments Reply
    Coates, Laura C.
    Helliwell, Philip S.
    [J]. JOURNAL OF RHEUMATOLOGY, 2016, 43 (09) : 1766 - 1766
  • [9] To compare the DAS-28 and the CPDAI (Composite Psoriatic Disease Activity Index) in predicting treatment change in Psoriatic Arthritis (PsA) patients
    Mumtaz, A.
    Gallagher, P.
    Veale, D. J.
    FitzGerald, O.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2010, 179 : S563 - S563
  • [10] Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score
    Schoels, Monika M.
    Aletaha, Daniel
    Alasti, Farideh
    Smolen, Josef S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (05) : 811 - 818
12345